HST Global, Inc. (HSTC) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
150 RESEARCH DR. HAMPTON, VA 23666 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 190 | 225 | 660 | 1,955 | 291 | ||||
| Cash and cash equivalents | 190 | 225 | 660 | 1,955 | 291 | ||||
| Total current assets: | 190 | 225 | 660 | 1,955 | 291 | ||||
| Noncurrent Assets | |||||||||
| TOTAL ASSETS: | 190 | 225 | 660 | 1,955 | 291 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 7,695 | 3,656 | 4,918 | 3,910 | 3,228 | 4,688 | |||
| Interest and dividends payable | ✕ | ✕ | 3,656 | 1,014 | 376,629 | ||||
| Accrued liabilities | 7,695 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 3,904 | 3,910 | (373,401) | 4,688 | |||||
| Debt | 2,957 | ||||||||
| Deferred compensation liability | 990,000 | ||||||||
| Due to related parties | 438,352 | 297,352 | 147,151 | 1,475 | 2,988,128 | 505,959 | |||
| Other undisclosed current liabilities | 1,014 | 376,629 | 1,692,251 | ||||||
| Total current liabilities: | 446,047 | 301,008 | 153,083 | 5,385 | 3,370,942 | 3,192,898 | |||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 446,047 | 301,008 | 153,083 | 5,385 | 3,370,942 | 3,192,898 | |||
| Equity | |||||||||
| Equity, attributable to parent | (445,857) | (300,783) | (152,423) | (3,430) | (3,370,942) | (3,192,607) | |||
| Common stock | 5,248 | 5,248 | 5,249 | 4,248 | 36,720 | 36,720 | |||
| Additional paid in capital | 5,417,236 | 5,417,236 | 5,417,236 | 5,358,236 | 2,384,824 | 2,384,824 | |||
| Accumulated deficit | (5,868,341) | (5,723,267) | (5,574,908) | (5,365,914) | (5,792,486) | (5,614,151) | |||
| Total equity: | (445,857) | (300,783) | (152,423) | (3,430) | (3,370,942) | (3,192,607) | |||
| TOTAL LIABILITIES AND EQUITY: | 190 | 225 | 660 | 1,955 | 291 | ||||
Income Statement (P&L) (USD)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (141,035) | (145,718) | (207,978) | (151,554) | (142,587) | (152,995) | ||
| Operating loss: | (141,035) | (145,718) | (207,978) | (151,554) | (142,587) | (152,995) | ||
| Nonoperating income (expense) | (4,039) | (2,642) | (1,014) | 578,126 | (35,748) | |||
| Interest and debt expense | (4,039) | (2,642) | (1,014) | 596,000 | 35,748 | 12,097 | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (149,113) | (151,002) | (210,006) | 1,022,572 | (142,587) | (140,898) | ||
| Other undisclosed income from continuing operations before income taxes | ||||||||
| Income (loss) from continuing operations before income taxes: | (149,113) | (151,002) | (210,006) | 1,022,572 | (142,587) | (140,898) | ||
| Income tax expense (benefit) | 31,156 | 43,888 | (89,580) | 37,450 | 56,131 | |||
| Income (loss) from continuing operations: | (149,113) | (119,846) | (166,118) | 932,992 | (105,137) | (84,767) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (119,846) | (166,118) | 932,992 | (105,137) | (84,767) | ||
| Other undisclosed net income (loss) | 4,039 | (28,514) | (42,874) | (506,420) | (73,198) | |||
| Net income (loss): | (145,074) | (148,360) | (208,992) | 426,572 | (178,335) | (84,767) | ||
| Other undisclosed net loss attributable to parent | (80,325) | |||||||
| Net income (loss) available to common stockholders, diluted: | (145,074) | (148,360) | (208,992) | 426,572 | (178,335) | (165,092) | ||
Comprehensive Income (USD)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (145,074) | (148,360) | (208,992) | 426,572 | (178,335) | (84,767) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (145,074) | (148,360) | (208,992) | 426,572 | (178,335) | (84,767) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.